| FSMDX | STSAX | FSMDX / STSAX | |
| Total Expense Ratio | 0.03 | 2.01 | 1% |
| Annual Report Gross Expense Ratio | 0.03 | 2.02 | 1% |
| Fund Existence | 14 years | 25 years | - |
| Gain YTD | 6.595 | -3.347 | -197% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 1000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 45B | 629M | 7,154% |
| Annual Yield % from dividends | 1.26 | 0.00 | - |
| Returns for 1 year | 1.88 | -18.28 | -10% |
| Returns for 3 years | 38.96 | -30.84 | -126% |
| Returns for 5 years | 48.61 | -48.89 | -99% |
| Returns for 10 years | 129.06 | -63.56 | -203% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BGX | 11.74 | 0.05 | +0.43% |
| Blackstone Long-Short Credit Income Fund | |||
| IHE | 82.09 | 0.23 | +0.28% |
| iShares US Pharmaceuticals ETF | |||
| ALITF | 17.00 | N/A | N/A |
| ALLIANCE WITAN PLC | |||
| HYSA | 15.12 | -0.01 | -0.03% |
| BondBloxx USD High Yld Bd Sect Rot ETF | |||
| DFUV | 44.29 | -0.08 | -0.17% |
| Dimensional US Marketwide Value ETF | |||